United States · Biotechnology startup
United States · Girihlet
Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies.
Funding reportedLast round: Debt financing
What company datasets say Girihlet raised
Funding, as reported
Reported in all$3.3Min dollars
Rounds4
Last roundDebt financing
Last round dateMar 2022
Investors listed4
Founders and team
From the SEC filings it signed: 2 on the team.
- Anitha JayaprakashExecutive Officer, Directori
- Ravi SachidananadamExecutive Officer, Directori
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Girihlet in front of investors. Or tell us what we have wrong.